Daiken Medical Co., Ltd. (TYO:7775)

Daiken Medical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	12,095	12,870	14,077	15,944	13,818	14,652
Market Cap Growth	-4.75%	-8.57%	-11.71%	15.38%	-5.69%	-16.26%
Enterprise Value	11,772	12,338	13,444	15,955	14,329	15,410
Last Close Price	421.00	448.00	469.14	507.96	424.02	431.23

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	13.85	13.96	12.83	16.14	19.41	17.63
PS Ratio	1.18	1.25	1.42	1.64	1.51	1.72
PB Ratio	1.59	1.66	1.87	2.27	2.10	2.27
P/TBV Ratio	1.59	1.66	1.88	2.28	2.10	2.28
P/FCF Ratio	50.39	53.63	14.76	11.45	17.47	15.74
P/OCF Ratio	21.33	22.70	12.57	10.25	13.97	12.93

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	1.15	1.20	1.35	1.64	1.57	1.80
EV/EBITDA Ratio	7.99	8.04	7.71	9.63	10.84	10.52
EV/EBIT Ratio	9.74	9.66	8.89	11.06	13.58	13.39
EV/FCF Ratio	49.05	51.41	14.09	11.45	18.12	16.55

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.28	0.29	0.27	0.31	0.42	0.46
Debt / EBITDA Ratio	1.43	1.48	1.18	1.29	2.08	2.00
Debt / FCF Ratio	-	9.45	2.15	1.54	3.48	3.15
Net Debt / Equity Ratio	-0.04	-0.07	-0.13	-0.08	0.04	0.06
Net Debt / EBITDA Ratio	-0.22	-0.33	-0.54	-0.36	0.18	0.28
Net Debt / FCF Ratio	-	-2.12	-0.99	-0.43	0.30	0.45
Asset Turnover	0.93	0.91	0.90	0.89	0.83	0.79
Inventory Turnover	3.91	4.20	4.08	3.91	3.67	3.28
Quick Ratio	1.83	1.97	1.93	1.56	1.50	1.57
Current Ratio	2.54	2.58	2.47	2.02	1.97	2.09
Return on Equity (ROE)	11.68%	12.06%	15.09%	14.51%	10.92%	13.16%
Return on Assets (ROA)	6.87%	7.08%	8.52%	8.19%	6.01%	6.64%
Return on Invested Capital (ROIC)	12.34%	13.67%	16.94%	14.99%	10.71%	12.02%
Return on Capital Employed (ROCE)	14.40%	14.80%	18.10%	18.80%	13.80%	14.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	7.22%	7.16%	7.79%	6.20%	5.15%	5.67%
FCF Yield	1.98%	1.86%	6.78%	8.74%	5.72%	6.35%
Payout Ratio	-	71.58%	55.79%	58.00%	79.35%	69.07%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error